Compare · 3 funds side by side · dividends reinvested

IBRN, XLV and VOO

Story of the three · Growth5Y$10,000 five years agoDividends reinvested · all three on one scale$17,749VOO · best of the three

02 / 04

IBRN, XLV and VOO, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

Vanguard S&P 500 ETFLow-Cost Core · S&P 5000.03%1.07%+11.5%+11.9%+24.1%+12.2%−8.9%12.7%$1.00T1.4

State Street Health Care Select Sector SPDR ETFSectors · Health care0.08%1.39%+20.4%+29.7%+16.2%+8.5%−10.5%16.4%$49.1B1.8

iShares Neuroscience and Healthcare ETFSectors · Health care0.47%0.96%+3.0%+11.3%+21.0%[…]−26.3%26.7%$7M2.9

Rank among the three1st → 3rdFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 3, 2026 · returns include dividends · since: IBRN 2022 · XLV 1998 · VOO 2010

Head to Head

Swap sides Versus in desk

Head to Head

iShares Neuroscience and Healthcare ETF · $7M[…]

IBRN

XLV

State Street Health Care Select Sector SPDR ETF · $49.1B$15,068

$10,000 five years ago, dividends reinvested · they hold 0.6% in common

IBRNMeasureXLV

+3.0%Year to dateJan 1 → Nov 3+20.4%

+11.3%1 yearTotal return+29.7%

+21.0%3 years · per year$10,000 became $17,703 · $15,709+16.2%

[…]5 years · per year$10,000 became […] · $15,068+8.5%

0.47%Expense ratio$47 · $8 a year on $10k · lower is better0.08%

0.96%Trailing 12-mo yield$96 · $139 a year on $10k1.39%

−26.3%Worst dropSmaller is better−10.5%

26.7%VolatilityLower is calmer16.4%

IBRNXLV Winner of the row, in its colourEach row: the bigger of the two fills its side

1–6XLV wins

End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

IBRN vs XLV: Top 5 Holdings

Today

IBRN

23.5%in top 5

XLV

in top 545.0%

IBRNStockXLV

not top 5LLY16.5%

not top 5JNJ9.9%

not top 5ABBV7.7%

5.6%BIIBnot top 5

not top 5UNH5.5%

not top 5MRK5.4%

4.8%ALKSnot top 5

4.6%NBIXnot top 5

4.4%EWTXnot top 5

4.2%PTCTnot top 5

Held in common0.6%

End-of-day Nov 3, 2026 · share of each fund

IBRN vs XLV Returns, Every Period

iSharesIBRN

+11.3%

past year

XLVSPDR

+29.7%

past year

IBRNXLVFaded: behind in that period

1–2XLV wins

End-of-day Nov 3, 2026 · dividends in · faded = behind in that period

IBRN vs XLV

YTD

iSharesIBRN

+3.0%

XLVSPDR

+20.4%

+3.0%Year to date+20.4%

−26.3%Worst drop · 1Y−10.5%

26.7%Volatility · 1Y16.4%

1.0%Yield1.4%

$6.6MAssets$49.1B

4–0XLV wins

End-of-day Nov 3, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: IBRN, XLV, VOO

Today

0.03%lowest, VOO

FundExpense ratioFee$10k

VOO0.03%$3

XLV0.08%$8

IBRN0.47%$47

End-of-day Nov 3, 2026 · fee on $10,000 a year

Yields: IBRN, XLV, VOO

1.39%highest, XLV

FundTrailing yieldYield$10k

XLV1.39%$139

VOO1.07%$107

IBRN0.96%$96

End-of-day Nov 3, 2026 · trailing 12-month yield

Income After Fees on $10,000

$131most kept, XLV

XLV$139 − $8 = $131

VOO$107 − $3 = $104

IBRN$96 − $47 = $49

KeptFee

End-of-day Nov 3, 2026 · yield in dollars minus the fee

Overlap: IBRN, XLV, VOO

Today

9.3%most shared, XLV and VOO

IBRNXLVVOO

IBRN—0.6%0.1%

XLV0.6%—9.3%

VOO0.1%9.3%—

End-of-day Nov 3, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 3 ETFs

+29.7%XLV, at 16.4% volatility

VOOWorst drop−8.9%12.7% vol

XLVWorst drop−10.5%16.4% vol

IBRNWorst drop−26.3%26.7% vol

End-of-day Nov 3, 2026 · up and left is better

Paid More vs Made More

YTD

XLVVOO

+20.4%Year to date+11.5%

1.4%Yield1.1%

+29.7%Past year+11.9%

0.08%Fee0.03%

3–1XLV wins

End-of-day Nov 3, 2026

Popular Pairs Near These Three

SPYM vs SPY

YTD

SPDRSPYM

+11.5%

SPYSPDR

+11.5%

+11.5%Year to date+11.5%

1.0%Yield1.0%

$185BAssets$798B

0–0level

End-of-day Nov 3, 2026

VOO vs IVV

YTD

VanguardVOO

+11.5%

IVViShares

+11.6%

+11.5%Year to date+11.6%

1.1%Yield1.1%

$1.00TAssets$872B

1–0IVV wins

End-of-day Nov 3, 2026

SCHD vs VIG

YTD

SchwabSCHD

+32.8%

VIGVanguard

+14.0%

+32.8%Year to date+14.0%

3.0%Yield1.5%

$121BAssets$109B

2–0SCHD wins

End-of-day Nov 3, 2026